Biglycan in the Skeleton
暂无分享,去创建一个
B. Loeys | M. Young | V. Kram | P. Jani | J. Meester | R. Shainer
[1] S. Shibata,et al. Expression, localization and synthesis of small leucine-rich proteoglycans in developing mouse molar tooth germ , 2020, European journal of histochemistry : EJH.
[2] L. Schaefer,et al. Breaking down chronic inflammatory diseases: the role of biglycan in promoting a switch between inflammation and autophagy , 2019, The FEBS journal.
[3] J. Halper,et al. Does BMP2 play a role in the pathogenesis of equine degenerative suspensory ligament desmitis? , 2018, BMC Research Notes.
[4] S. Mundlos,et al. Impaired proteoglycan glycosylation, elevated TGF-β signaling, and abnormal osteoblast differentiation as the basis for bone fragility in a mouse model for gerodermia osteodysplastica , 2018, PLoS genetics.
[5] Jean X. Jiang,et al. Age‐Related Deterioration of Bone Toughness Is Related to Diminishing Amount of Matrix Glycosaminoglycans (GAGs) , 2018, JBMR plus.
[6] W. Landis,et al. A Force on the Crown and Tug of War in the Periodontal Complex , 2018, Journal of dental research.
[7] K. Itoh,et al. Novel roles of glycosaminoglycans in the degradation of type I collagen by cathepsin K , 2017, Glycobiology.
[8] N. Bhattacharyya,et al. Small leucine rich proteoglycans, a novel link to osteoclastogenesis , 2017, Scientific Reports.
[9] G. Mortier,et al. Loss-of-function mutations in the X-linked biglycan gene cause a severe syndromic form of thoracic aortic aneurysms and dissections , 2016, Genetics in Medicine.
[10] M. Mörgelin,et al. The Tyrosine Sulfate Domain of Fibromodulin Binds Collagen and Enhances Fibril Formation* , 2016, The Journal of Biological Chemistry.
[11] Dongsup Kim,et al. BGN Mutations in X-Linked Spondyloepimetaphyseal Dysplasia. , 2016, American journal of human genetics.
[12] S. Ricard-Blum,et al. Biglycan potentially regulates angiogenesis during fracture repair by altering expression and function of endostatin. , 2016, Matrix biology : journal of the International Society for Matrix Biology.
[13] I. Kakizaki,et al. Chondroitin sulfate cluster of epiphycan from salmon nasal cartilage defines binding specificity to collagens. , 2015, Glycobiology.
[14] Casie E. Horgan,et al. Compensatory fetal membrane mechanisms between biglycan and decorin in inflammation , 2015, Molecular reproduction and development.
[15] M. Somerman,et al. Fibromodulin and Biglycan Modulate Periodontium through TGFβ/BMP Signaling , 2014, Journal of dental research.
[16] M. Young,et al. Biglycan modulates angiogenesis and bone formation during fracture healing. , 2014, Matrix biology : journal of the International Society for Matrix Biology.
[17] M. Bönecker,et al. Immunohistochemical expression of biglycan and decorin in the pulp tissue of human primary teeth during resorption. , 2013, Brazilian oral research.
[18] A. Kariminejad,et al. Defective initiation of glycosaminoglycan synthesis due to B3GALT6 mutations causes a pleiotropic Ehlers-Danlos-syndrome-like connective tissue disorder. , 2013, American journal of human genetics.
[19] S. Weinbaum,et al. Mechanosensation and transduction in osteocytes. , 2013, Bone.
[20] M. Wendel,et al. The glycosylation profile of osteoadherin alters during endochondral bone formation. , 2013, Bone.
[21] Weikai Zhang,et al. Glycosaminoglycan chains of biglycan promote bone morphogenetic protein-4-induced osteoblast differentiation. , 2012, International journal of molecular medicine.
[22] K. Hultenby,et al. Osteoadherin Accumulates in the Predentin towards the Mineralization Front in the Developing Tooth , 2012, PloS one.
[23] Jennifer J Westendorf,et al. Update on Wnt signaling in bone cell biology and bone disease. , 2012, Gene.
[24] J. Gutkind,et al. Modulation of canonical Wnt signaling by the extracellular matrix component biglycan , 2011, Proceedings of the National Academy of Sciences.
[25] M. Yamauchi,et al. Role of glycosaminoglycans of biglycan in BMP-2 signaling. , 2011, Biochemical and biophysical research communications.
[26] Valerie M. Weaver,et al. The extracellular matrix at a glance , 2010, Journal of Cell Science.
[27] Xiaoyan Wang,et al. Matrix protein biglycan induces osteoblast differentiation through extracellular signal-regulated kinase and Smad pathways. , 2010, Biological & pharmaceutical bulletin.
[28] R. Iozzo,et al. Proteoglycans in health and disease: novel regulatory signaling mechanisms evoked by the small leucine‐rich proteoglycans , 2010, The FEBS journal.
[29] Byoungjae Kim,et al. Glycan profiling of a defect in decorin glycosylation in equine systemic proteoglycan accumulation, a potential model of progeroid form of Ehlers-Danlos syndrome. , 2010, Archives of biochemistry and biophysics.
[30] Li Sun,et al. The Role of FSH and TSH in Bone Loss and Its Clinical Relevance , 2010, Current osteoporosis reports.
[31] A. Oldberg,et al. The role of small leucine-rich proteoglycans in collagen fibrillogenesis. , 2010, Matrix biology : journal of the International Society for Matrix Biology.
[32] Joseph M. Wallace,et al. Inbred Strain-Specific Effects of Exercise in Wild Type and Biglycan Deficient Mice , 2010, Annals of Biomedical Engineering.
[33] M. Karsdal,et al. Biglycan and fibromodulin have essential roles in regulating chondrogenesis and extracellular matrix turnover in temporomandibular joint osteoarthritis. , 2010, The American journal of pathology.
[34] D. Heinegård,et al. The Tyrosine Sulfate-rich Domains of the LRR Proteins Fibromodulin and Osteoadherin Bind Motifs of Basic Clusters in a Variety of Heparin-binding Proteins, Including Bioactive Factors* , 2009, The Journal of Biological Chemistry.
[35] Pei-hua Wang,et al. Decorin gene delivery inhibits cardiac fibrosis in spontaneously hypertensive rats by modulation of transforming growth factor-beta/Smad and p38 mitogen-activated protein kinase signaling pathways. , 2009, Human gene therapy.
[36] J. Pfeilschifter,et al. Biglycan, a Danger Signal That Activates the NLRP3 Inflammasome via Toll-like and P2X Receptors* , 2009, The Journal of Biological Chemistry.
[37] Ronald T Raines,et al. Collagen structure and stability. , 2009, Annual review of biochemistry.
[38] M. Karsdal,et al. Local communication on and within bone controls bone remodeling. , 2009, Bone.
[39] A. Al Haj Zen,et al. Syndromic and non‐syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathway , 2009, The Journal of pathology.
[40] A. Kulkarni,et al. Genetic evidence for key roles of decorin and biglycan in dentin mineralization. , 2009, Matrix biology : journal of the International Society for Matrix Biology.
[41] R. Iozzo,et al. Genetic Evidence for the Coordinated Regulation of Collagen Fibrillogenesis in the Cornea by Decorin and Biglycan* , 2009, Journal of Biological Chemistry.
[42] A. Oldberg,et al. Homologous Sequence in Lumican and Fibromodulin Leucine-rich Repeat 5-7 Competes for Collagen Binding* , 2009, Journal of Biological Chemistry.
[43] M. Raspanti,et al. Glycosaminoglycans show a specific periodic interaction with type I collagen fibrils. , 2008, Journal of structural biology.
[44] Ego Seeman,et al. Bone remodelling: its local regulation and the emergence of bone fragility. , 2008, Best practice & research. Clinical endocrinology & metabolism.
[45] R. Moats,et al. Biglycan Overexpression on Tooth Enamel Formation in Transgenic Mice , 2008, Anatomical record.
[46] A. Bhosale,et al. Articular cartilage: structure, injuries and review of management , 2008 .
[47] M. Young,et al. Fibromodulin-Deficient Mice Reveal Dual Functions for Fibromodulin in Regulating Dental Tissue and Alveolar Bone Formation , 2008, Cells Tissues Organs.
[48] R. Iozzo,et al. Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction* , 2008, Journal of Biological Chemistry.
[49] D. Vigetti,et al. Influence of collagen-fibril-based coatings containing decorin and biglycan on osteoblast behavior. , 2008, Journal of biomedical materials research. Part A.
[50] A. Oldberg,et al. Fibromodulin Binds Collagen Type I via Glu-353 and Lys-355 in Leucine-rich Repeat 11* , 2007, Journal of Biological Chemistry.
[51] R. Iozzo,et al. The glycosaminoglycan chain of decorin plays an important role in collagen fibril formation at the early stages of fibrillogenesis , 2007, The FEBS journal.
[52] D. Heymann,et al. Proteoglycans: key partners in bone cell biology , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.
[53] M. Young,et al. Biglycan Deficiency Causes Spontaneous Aortic Dissection and Rupture in Mice , 2007, Circulation.
[54] R. Iozzo,et al. Impaired posterior frontal sutural fusion in the biglycan/decorin double deficient mice. , 2007, Bone.
[55] Joseph M. Wallace,et al. Exercise-induced changes in the cortical bone of growing mice are bone- and gender-specific. , 2007, Bone.
[56] P. Roughley,et al. SLRP interaction can protect collagen fibrils from cleavage by collagenases. , 2006, Matrix biology : journal of the International Society for Matrix Biology.
[57] M. Young,et al. Small leucine-rich proteoglycans in the aging skeleton. , 2006, Journal of musculoskeletal & neuronal interactions.
[58] D. Scharnweber,et al. Fibrillogenesis of collagen types I, II, and III with small leucine-rich proteoglycans decorin and biglycan. , 2006, Biomacromolecules.
[59] Joseph M. Wallace,et al. The mechanical phenotype of biglycan-deficient mice is bone- and gender-specific. , 2006, Bone.
[60] M. Young,et al. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. , 2006, Bone.
[61] A. Oldberg,et al. Fibromodulin-deficient Mice Display Impaired Collagen Fibrillogenesis in Predentin as Well as Altered Dentin Mineralization and Enamel Formation , 2006, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[62] A. Zallone,et al. FSH Directly Regulates Bone Mass , 2006, Cell.
[63] Ahrar Khan,et al. Degenerative suspensory ligament desmitis as a systemic disorder characterized by proteoglycan accumulation , 2006, BMC veterinary research.
[64] L. Kiesel,et al. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers–Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (β4GalT-7) , 2006, Journal of Molecular Medicine.
[65] A. Boskey,et al. Variation in Mineral Properties in Normal and Mutant Bones and Teeth , 2006, Cells Tissues Organs.
[66] D. Bidwell,et al. Formation , 2006, Revue Francophone d'Orthoptie.
[67] M. Young,et al. Targeted Disruption of Two Small Leucine-rich Proteoglycans, Biglycan and Decorin, Excerpts Divergent Effects on Enamel and Dentin Formation , 2005, Calcified Tissue International.
[68] A. Holmlund,et al. Expression of proteoglycan mRNA in patients with painful clicking and chronic closed lock of the temporomandibular joint. , 2005, International journal of oral and maxillofacial surgery.
[69] C. Stuelten,et al. Extracellular Matrix Proteoglycans Control the Fate of Bone Marrow Stromal Cells* , 2005, Journal of Biological Chemistry.
[70] Marian F Young,et al. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. , 2005, The Journal of clinical investigation.
[71] R. Iozzo,et al. Decorin, a Novel Player in the Insulin-like Growth Factor System* , 2005, Journal of Biological Chemistry.
[72] H. Larjava,et al. Colocalization of the collagen-binding proteoglycans decorin, biglycan, fibromodulin and lumican with different cells in human gingiva. , 2005, Journal of periodontal research.
[73] M. Young,et al. Transforming growth factor beta stimulation of biglycan gene expression is potentially mediated by sp1 binding factors , 2004, Journal of cellular biochemistry.
[74] M. Young,et al. The small leucine‐rich proteoglycan biglycan modulates BMP‐4‐induced osteoblast differentiation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] H. Sasamura,et al. Functional characterization of podocan, a member of a new class in the small leucine‐rich repeat protein family , 2004, FEBS letters.
[76] D. Heinegård,et al. Identification of Tyrosine Sulfation in Extracellular Leucine-rich Repeat Proteins Using Mass Spectrometry* , 2004, Journal of Biological Chemistry.
[77] T. L. Andersen,et al. Biglycan Deficiency Interferes With Ovariectomy‐Induced Bone Loss , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[78] E. Schönherr,et al. Differential roles for small leucine-rich proteoglycans in bone formation. , 2003, European cells & materials.
[79] T. Zorn,et al. Distribution of biglycan and decorin in rat dental tissue. , 2003, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[80] J. Balasch. Sex steroids and bone: current perspectives. , 2003, Human reproduction update.
[81] Charlotte Wiberg,et al. Biglycan Organizes Collagen VI into Hexagonal-like Networks Resembling Tissue Structures* , 2002, The Journal of Biological Chemistry.
[82] J. Peragallo,et al. A Syndrome of Joint Laxity and Impaired Tendon Integrity in Lumican- and Fibromodulin-deficient Mice* 210 , 2002, The Journal of Biological Chemistry.
[83] Marian F Young,et al. Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. , 2002, Glycobiology.
[84] M. Goldberg,et al. Biglycan is a Repressor of Amelogenin Expression and Enamel Formation: An Emerging Hypothesis , 2002, Journal of dental research.
[85] A Boyde,et al. Phenotypic Effects of Biglycan Deficiency Are Linked to Collagen Fibril Abnormalities, Are Synergized by Decorin Deficiency, and Mimic Ehlers‐Danlos‐Like Changes in Bone and Other Connective Tissues , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[86] M. Young,et al. Biglycan knockout mice: New models for musculoskeletal diseases , 2002, Glycoconjugate Journal.
[87] S. Chakravarti. Functions of lumican and fibromodulin: Lessons from knockout mice , 2002, Glycoconjugate Journal.
[88] A. Oldberg,et al. Abnormal collagen fibrils in tendons of biglycan/fibromodulin‐deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[89] S. Shi,et al. Age‐Related Osteoporosis in Biglycan‐Deficient Mice Is Related to Defects in Bone Marrow Stromal Cells , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[90] D. Arnott,et al. WISP-1 Binds to Decorin and Biglycan* , 2001, The Journal of Biological Chemistry.
[91] K. Walsh,et al. Decorin-mediated Signal Transduction in Endothelial Cells , 2001, The Journal of Biological Chemistry.
[92] K. Shigemasa,et al. Gene expression and immunohistochemical localization of decorin and biglycan in association with early bone formation in the developing mandible. , 2001, Journal of oral science.
[93] K. Uzawa,et al. Differential expression of decorin and biglycan genes during mouse tooth development. , 2001, Matrix biology : journal of the International Society for Matrix Biology.
[94] E. Schipani,et al. Fibromodulin is expressed by both chondrocytes and osteoblasts during fetal bone development , 2001, Journal of cellular biochemistry.
[95] A. Paterson,et al. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. , 2001, The American journal of pathology.
[96] E. Vuorio,et al. Murine fibromodulin: cDNA and genomic structure, and age-related expression and distribution in the knee joint. , 2001, The Biochemical journal.
[97] Inna Chervoneva,et al. Differential Expression of Lumican and Fibromodulin Regulate Collagen Fibrillogenesis in Developing Mouse Tendons , 2000, The Journal of cell biology.
[98] O. Reizes,et al. Cell Surface Heparan Sulfate Proteoglycans: Selective Regulators of Ligand-Receptor Encounters* , 2000, The Journal of Biological Chemistry.
[99] J. Braekman,et al. Triterpene saponins, quaternary ammonium compounds, phosphatidyl cholines, and amino acids in the pronotal and elytral secretions of Platyphora opima and Desmogramma subtropica. , 2000, Journal of natural products.
[100] H. Väänänen,et al. The cell biology of osteoclast function. , 2000, Journal of cell science.
[101] P. Roughley,et al. Modulation of keratan sulfate synthesis on lumican by the action of cytokines on human articular chondrocytes. , 1999, Matrix biology : journal of the International Society for Matrix Biology.
[102] F. Reinholt,et al. Fibromodulin-null Mice Have Abnormal Collagen Fibrils, Tissue Organization, and Altered Lumican Deposition in Tendon* , 1999, The Journal of Biological Chemistry.
[103] S. Goldstein,et al. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice , 1998, Nature Genetics.
[104] Renato V. Iozzo,et al. Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.
[105] P. Roughley,et al. Changes with age in the structure of fibromodulin in human articular cartilage. , 1996, Osteoarthritis and cartilage.
[106] Oldberg,et al. Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 (*) , 1995, The Journal of Biological Chemistry.
[107] M. Young,et al. The X-chromosomal human biglycan gene BGN is subject to X inactivation but is transcribed like an X-Y homologous gene , 1995, Human Genetics.
[108] H Kresse,et al. Interaction of Biglycan with Type I Collagen (*) , 1995, The Journal of Biological Chemistry.
[109] T Matsumoto,et al. Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity. , 1994, The Journal of biological chemistry.
[110] E. Ruoslahti,et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.
[111] G Pogány,et al. The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate. , 1994, Archives of biochemistry and biophysics.
[112] P. Roughley,et al. Non-proteoglycan forms of biglycan increase with age in human articular cartilage. , 1993, The Biochemical journal.
[113] B. Clarke,et al. Distribution of noncollagenous proteins in the matrix of adult human bone: Evidence of anatomic and functional heterogeneity , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[114] B. Johnstone,et al. Identification and characterization of glycanated and non-glycanated forms of biglycan and decorin in the human intervertebral disc. , 1993, The Biochemical journal.
[115] J. Hassell,et al. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. , 1993, Experimental eye research.
[116] T. Hardingham,et al. Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[117] M. Young,et al. Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[118] E. Ruoslahti,et al. Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.
[119] D. Heinegård,et al. Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.
[120] J. Gallagher,et al. Specific association of iduronic acid-rich dermatan sulphate with the extracellular matrix of human skin fibroblasts cultured on collagen gels. , 1983, The Biochemical journal.
[121] J. Keller,et al. Interactions of cellular glycosaminoglycans with plasma fibronectin and collagen. , 1982, Biochimica et biophysica acta.
[122] P. Roughley,et al. O-Linked oligosaccharides of human articular cartilage proteoglycan. , 1982, Biochimica et biophysica acta.
[123] Frank P Luyten,et al. Uncovering the periosteum for skeletal regeneration: the stem cell that lies beneath. , 2015, Bone.
[124] V. Lefebvre,et al. Vertebrate skeletogenesis. , 2010, Current topics in developmental biology.
[125] J. Pfeilschifter,et al. Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin. , 2007, The American journal of pathology.
[126] M. Yamauchi,et al. Biglycan is a positive modulator of BMP-2 induced osteoblast differentiation. , 2006, Advances in experimental medicine and biology.
[127] S. Saika,et al. Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-α signaling , 2005 .
[128] S. Saika,et al. Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signaling. , 2005, Developmental biology.
[129] R. Jilka,et al. Sex steroids and bone. , 2002, Recent progress in hormone research.
[130] M Goldberg,et al. Proteoglycans in dentinogenesis. , 2001, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.
[131] P. Roughley,et al. Changes in leucine-rich repeat proteoglycans during maturation of the bovine growth plate. , 2001, Matrix biology : journal of the International Society for Matrix Biology.
[132] M. Götte,et al. Functions of cell surface heparan sulfate proteoglycans. , 1999, Annual review of biochemistry.
[133] P. Robey. Vertebrate mineralized matrix proteins: structure and function. , 1996, Connective tissue research.
[134] E. Ruoslahti,et al. Negative regulation of transforming growth factor-beta by the proteoglycan decorin. , 1990, Nature.